С. О. Бачурин

5.4k citations

220 papers · 4.2k indexed · h-index 35

Molecular Biology top 5%
Pharmacology top 0.5%
Organic Chemistry top 1%
Physiology top 2%
Computational Theory and Mathematics top 0.5%

Co-authors: A. A. Ustyugov E. F. Shevtsova Elena Bovina Gjumrakch Aliev Галина Ф. Махаева E. G. Kireeva Alexey N. Proshin А. Yu. Aksinenko
Topics: Cholinesterase and Neurodegenerative Diseases (76 papers)Neuroscience and Neuropharmacology Research (42 papers)Computational Drug Discovery Methods (41 papers)
Cited by: Biological Psychiatry Pharmacology Computational Theory and Mathematics
Journals: The Lancet Journal of Biological ChemistrySHILAP Revista de lepidopterología
Partner nations: Russia United States United Kingdom

In The Last Decade

С. О. Бачурин

208 papers receiving 4.1k citations

Peers

Countries citing papers authored by С. О. Бачурин

Since Specialization

Citations

This map shows the geographic impact of С. О. Бачурин's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by С. О. Бачурин with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites С. О. Бачурин more than expected).

Fields of papers citing papers by С. О. Бачурин

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by С. О. Бачурин. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by С. О. Бачурин. The network helps show where С. О. Бачурин may publish in the future.

Co-authorship network of co-authors of С. О. Бачурин

This figure shows the co-authorship network connecting the top 25 collaborators of С. О. Бачурин. A scholar is included among the top collaborators of С. О. Бачурин based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with С. О. Бачурин. С. О. Бачурин is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Role of Hydrogen Sulfide in the Localization and Structural–Functional Organization of p53 Following Traumatic Brain Injury: Development of a YOLO Model for Detection and Quantification of Apoptotic Nuclei 2025 ·International Journal of Molecular Sciences ·(unknown),С. О. Бачурин,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown)	2
2	Neuroprotective thiourea derivative uncouples mitochondria and exerts weak protonophoric action on lipid membranes 2024 ·Chemico-Biological Interactions ·Yuri N. Antonenko,(unknown),Tatyana I. Rokitskaya,(unknown),(unknown),Еlena А. Kotova,(unknown),С. О. Бачурин,E. F. Shevtsova	0
3	Combining Experimental and Computational Methods to Produce Conjugates of Anticholinesterase and Antioxidant Pharmacophores with Linker Chemistries Affecting Biological Activities Related to Treatment of Alzheimer’s Disease 2024 ·Molecules ·Галина Ф. Махаева,N. V. Kovaleva,Елена В. Рудакова,Natalia P. Boltneva,Sofya V. Lushchekina,T. Yu. Astakhova,(unknown),И. В. Серков,Alexey N. Proshin,(unknown),(unknown),(unknown),(unknown),Alexey A. Terentiev,Eugene V. Radchenko,Vladimir A. Palyulin,С. О. Бачурин,Rudy J. Richardson	11
4	Synthesis of conjugates of ipidacrine with oxa/azaheterocycles and their potential as agents for the treatment of Alzheimer’s disease 2024 ·Russian Chemical Bulletin ·О. Г. Худина,(unknown),Галина Ф. Махаева,(unknown),Natalia P. Boltneva,(unknown),N. V. Kovaleva,Елена В. Рудакова,С. О. Бачурин,В. И. Салоутин	5
5	Creation and Study of the Mechanism of Action of Compounds of a New Class of Positive Modulators of AMPA Receptors – Derivatives of 3,7-Diazabicyclo[3.3.1]nonanes 2023 ·V. V. Grigoriev,(unknown),Vladimir A. Palyulin,(unknown),K. V. Anokhin,С. О. Бачурин	0
6	New Adamantane-Containing Edaravone Conjugates as Potential Neuroprotective Agents for ALS Treatments 2023 ·Molecules ·(unknown),E. F. Shevtsova,V. V. Grigoriev,А. Yu. Aksinenko,A. A. Ustyugov,D. A. Steinberg,(unknown),(unknown),(unknown),(unknown),(unknown),Галина Ф. Махаева,Владимир Петрович Фисенко,(unknown),(unknown),С. О. Бачурин	3
7	Multifunctional Inhibitors of Cholinesterases for the Therapy of Alzheimer’s Disease (A Review) 2023 ·Russian Journal of General Chemistry ·Галина Ф. Махаева,С. О. Бачурин	9
8	Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors: N-Functionalization Determines the Multitarget Anti-Alzheimer’s Activity Profile 2022 ·Molecules ·Галина Ф. Махаева,N. V. Kovaleva,Natalia P. Boltneva,Елена В. Рудакова,Sofya V. Lushchekina,T. Yu. Astakhova,И. В. Серков,Alexey N. Proshin,Eugene V. Radchenko,Vladimir A. Palyulin,Jan Korábečný,Ondřej Soukup,С. О. Бачурин,Rudy J. Richardson	19
9	Pharmacological sequestration of mitochondrial calcium uptake protects against dementia and β-amyloid neurotoxicity 2022 ·Scientific Reports ·E. F. Shevtsova,Plamena R. Angelova,(unknown),Noemí Esteras,(unknown),(unknown),P. N. Shevtsov,(unknown),Владимир Петрович Фисенко,С. О. Бачурин,Andrey Y. Abramov	14
10	Bis(Benzofuran–1,3-N,N-heterocycle)s as Symmetric and Synthetic Drug Leads against Yellow Fever Virus 2022 ·International Journal of Molecular Sciences ·(unknown),S. Jayakumar,(unknown),Pieter Leyssen,Johan Neyts,С. О. Бачурин,Jih Ru Hwu,Shwu‐Chen Tsay	2
11	Novel potent bifunctional carboxylesterase inhibitors based on a polyfluoroalkyl-2-imino-1,3-dione scaffold 2021 ·European Journal of Medicinal Chemistry ·Галина Ф. Махаева,Sofya V. Lushchekina,Natalia P. Boltneva,Olga G. Serebryakova,N. V. Kovaleva,Елена В. Рудакова,(unknown),Evgeny V. Shchegolkov,Yanina V. Burgart,(unknown),Alexey A. Terentiev,Eugene V. Radchenko,Vladimir A. Palyulin,В. И. Салоутин,С. О. Бачурин,Rudy J. Richardson	17
12	Conjugation of Aminoadamantane and γ-Carboline Pharmacophores Gives Rise to Unexpected Properties of Multifunctional Ligands 2021 ·Molecules ·С. О. Бачурин,Галина Ф. Махаева,E. F. Shevtsova,А. Yu. Aksinenko,V. V. Grigoriev,P. N. Shevtsov,(unknown),(unknown),N. V. Kovaleva,(unknown),Natalia P. Boltneva,Sofya V. Lushchekina,(unknown),(unknown),(unknown),Елена В. Рудакова,Владимир Петрович Фисенко,Elena Bovina,Rudy J. Richardson	18
13	Mitochondria as a promising target for developing novel agents for treating Alzheimer's disease 2020 ·Medicinal Research Reviews ·E. F. Shevtsova,(unknown),(unknown),P. N. Shevtsov,С. О. Бачурин	27
14	In a search for efficient treatment for amyotrophic lateral sclerosis: Old drugs for new approaches 2020 ·Medicinal Research Reviews ·Michail S. Kukharsky,Veronika Skvortsova,С. О. Бачурин,Vladimir L. Buchman	16
15	New Hybrids of 4-Amino-2,3-polymethylene-quinoline and p-Tolylsulfonamide as Dual Inhibitors of Acetyl- and Butyrylcholinesterase and Potential Multifunctional Agents for Alzheimer’s Disease Treatment 2020 ·Molecules ·Галина Ф. Махаева,N. V. Kovaleva,Natalia P. Boltneva,Sofya V. Lushchekina,T. Yu. Astakhova,Елена В. Рудакова,Alexey N. Proshin,И. В. Серков,Eugene V. Radchenko,Vladimir A. Palyulin,С. О. Бачурин,Rudy J. Richardson	37
16	Conjugates of methylene blue with γ-carboline derivatives as new multifunctional agents for the treatment of neurodegenerative diseases 2019 ·Scientific Reports ·С. О. Бачурин,Галина Ф. Махаева,E. F. Shevtsova,Natalia P. Boltneva,N. V. Kovaleva,Sofya V. Lushchekina,Елена В. Рудакова,(unknown),(unknown),В. Б. Соколов,А. Yu. Aksinenko,Владимир Петрович Фисенко,Rudy J. Richardson,Gjumrakch Aliev	24
17	Novel Positive Allosteric Modulators of AMPA Receptors Based on 3,7-Diazabicyclo[3.3.1]nonane Scaffold 2019 ·Molecular Neurobiology ·(unknown),Dmitry S. Karlov,Т. А. Воронина,V. V. Grigoriev,A. A. Ustyugov,С. О. Бачурин,Vladimir A. Palyulin	19
18	Individual Differences in Behavioural Despair Predict Brain GSK-3beta Expression in Mice: The Power of a Modified Swim Test 2016 ·Neural Plasticity ·Tatyana Strekalova,(unknown),E. F. Shevtsova,О. Е. Зубарева,(unknown),Harry Steinbusch,С. О. Бачурин,Klaus‐Peter Lesch	24
19	Thiamine and benfotiamine improve memory, decrease depressive-like behavior and reduce brain expression of GSK3 beta in mice 2014 ·Open Repository and Bibliography (University of Liège) ·(unknown),E. F. Shevtsova,Julie Vignisse,О. Е. Зубарева,(unknown),Harry W.M. Steinbusch,С. О. Бачурин,Lucien Bettendorff,Tatyana Strekalova	3
20	Influence of derivatives of arachidonic and docosohexaenic acids on AMPA receptors in Purkinje neurons and cognitive functions in mice 2010 ·Biology Bulletin ·V. V. Grigoriev,И. В. Серков,(unknown),(unknown),N. M. Gretskaya,В. В. Безуглов,С. О. Бачурин	2

About С. О. Бачурин

С. О. Бачурин is a scholar working on Pharmacology, Cellular and Molecular Neuroscience and Organic Chemistry, having authored 220 papers that have together received 4.2k indexed citations. Recurring topics across this work include Cholinesterase and Neurodegenerative Diseases (76 papers), Neuroscience and Neuropharmacology Research (42 papers) and Computational Drug Discovery Methods (41 papers). The work is most often cited by research in Biological Psychiatry (229 citations), Pharmacology (1.5k citations) and Computational Theory and Mathematics (767 citations). С. О. Бачурин has collaborated with scholars based in Russia, United States and United Kingdom. Frequent co-authors include A. A. Ustyugov, E. F. Shevtsova, Elena Bovina, Gjumrakch Aliev, Галина Ф. Махаева, E. G. Kireeva, Alexey N. Proshin, А. Yu. Aksinenko, Gregory F. Oxenkrug and Natalia P. Boltneva. Their work appears in journals such as The Lancet, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact